非典型帕金森症中的液体生物标志物:当前状况和未来的前景
Anastasia Bougea1, Carlo Colosimo2, Cristian Falup-Pecurariu3,4
11st Department of Neurology, Medical School, Eginition Hospital, National and Kapodistrian University of Athens, 11528, Athens, Greece. abougea@med.uoa.gr.
概括
诊断非典型帕金森综合征 (APS) 很困难,但像脑脊液 (CSF) 标志物这样的液体生物标志物显示出希望. 为了早期识别和预后,需要进一步的研究和人工智能.
科学领域:
- 神经学 神经学
- 生物化学 生化学
- 生物标志物研究 生物标志物研究
背景情况:
- 诊断非典型帕金森综合征 (APS) 存在挑战,原因是帕金森病 (PD) 的症状重叠,以及缺乏确切的诊断测试.
- 液体生物标志物为改善各种APS的识别和监测提供了潜在的途径.
- 目前的研究重点是利用这些生物标志物来提高诊断准确性和预后能力.
研究的目的:
- 在APS中提供流体生物标志物研究的最新审查.
- 探索这些生物标志物的潜在临床影响.
- 确定APS生物标志物开发的当前局限性和未来方向.
主要方法:
- 使用PubMed和Scopus进行了全面的文献搜索.
- 关键词包括特定的生物标志物 (Aβ42,α-synuclein,神经纤维光,tau),APS类型 (CBD,DLB,MSA,PSP) 和分析技术 (播种放大测试).
- 该审查综合了各种液体生物标志物的疗效和局限性的发现.
主要成果:
- 在APS中,α-synuclein的诊断疗效受到抗体和配体可用性的限制.
- 脑脊液 (CSF) 生物标志物表明阿尔茨海默病理和轴突损伤 (神经丝光链) 提供了宝贵的诊断和预后信息.
- 炎症标志物和microRNAs需要进一步验证;种植放大试验 (SAA) 目前是研究工具.
结论:
- 液体生物标记物,特别是脑脊髓瘤标记物,具有改善APS诊断和预后的巨大潜力.
- 进一步验证,多中心合作和基于AI的诊断对于临床实施至关重要.
- 克服生物标志物开发方面的挑战对于推进APS患者的护理至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405
01:24Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
01:37Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40